• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Jürgen Rockstroh - Articles and news items

Gilead logo

Gilead’s single tablet HIV Regimen Stribild® demonstrates durable viral suppression through three years of therapy

Industry news / 16 October 2013 / Gilead

Long-term data in treatment-naïve patients highlight Stribild’s sustained efficacy, safety and tolerability profile…

Merck logo

FDA approves new U.S. labeling for ISENTRESS® (raltegravir)

Industry news, News / 1 July 2013 / Merck

New U.S. labeling for ISENTRESS® (raltegravir) to include 240-week results from STARTMRK study…

Gilead logo

European Commission approves Stribild®

Industry news, News / 28 May 2013 / Gilead Sciences

Gilead Sciences announced that the European Commission has granted marketing authorization for Stribild®…

Gilead logo
Merck logo

FDA approves new labeling for ISENTRESS® (raltegravir)

Industry news, News / 21 May 2012 / Merck

The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study…

Merck logo


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +